LLY

1,085.09

+1.81%↑

JNJ

232.16

+1.19%↑

ABBV

213.26

+0.06%↑

UNH

383.22

+1.49%↑

AZN

187.9

+0.13%↑

LLY

1,085.09

+1.81%↑

JNJ

232.16

+1.19%↑

ABBV

213.26

+0.06%↑

UNH

383.22

+1.49%↑

AZN

187.9

+0.13%↑

LLY

1,085.09

+1.81%↑

JNJ

232.16

+1.19%↑

ABBV

213.26

+0.06%↑

UNH

383.22

+1.49%↑

AZN

187.9

+0.13%↑

LLY

1,085.09

+1.81%↑

JNJ

232.16

+1.19%↑

ABBV

213.26

+0.06%↑

UNH

383.22

+1.49%↑

AZN

187.9

+0.13%↑

LLY

1,085.09

+1.81%↑

JNJ

232.16

+1.19%↑

ABBV

213.26

+0.06%↑

UNH

383.22

+1.49%↑

AZN

187.9

+0.13%↑

Home・Aktien・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Open

BrancheGesundheitswesen

21.45

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

Max

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.6M -21M
Verkäufe	14M 54M
Gewinnspanne	-39.611
Angestellte	178
EBITDA	-7.7M -26M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-3.62% downside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	1B 2.2B
Vorheriger Eröffnungskurs	21.45
Vorheriger Schlusskurs	21.45

Nachrichtenstimmung

By Acuity

50%

154 / 344 Ranking in Healthcare

Day One Biopharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

26. Mai 2026, 16:52 UTC

Wichtige Nachrichtenereignisse

NYMEX Overview: Brent Crude Futures Up; Iran Warns of Retaliation After US Strike -- OPIS

26. Mai 2026, 23:57 UTC

Ergebnisse

Sociedad Quimica 1Q Rev $1.76B >SQM

26. Mai 2026, 23:57 UTC

Ergebnisse

Sociedad Quimica 1Q EPS $1.28 >SQM

26. Mai 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Continued AI Enthusiasm -- Market Talk

26. Mai 2026, 21:54 UTC

Ergebnisse

Webco Industries 3Q EPS $11.61 >WEBC

26. Mai 2026, 21:54 UTC

Ergebnisse

Webco Industries 3Q Sales $179.6M >WEBC

26. Mai 2026, 21:48 UTC

Market Talk

GE Aerospace's Repair Boom Should Last for Years -- Market Talk

26. Mai 2026, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

26. Mai 2026, 20:58 UTC

Akquisitionen, Fusionen, Übernahmen

Uber's $11.6 Billion Bid for DoorDash Rival Is About Future Proofing It From Robots -- Barrons.com

26. Mai 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

26. Mai 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

26. Mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

26. Mai 2026, 19:22 UTC

Market Talk

Cryptocurrencies Add to Losses in Afternoon Trading -- Market Talk

26. Mai 2026, 19:17 UTC

Market Talk

Oil Recovers Some Losses on U.S.-Iran Skirmishes -- Market Talk

26. Mai 2026, 18:56 UTC

Market Talk

U.S. Natural Gas Futures Slip in Rangebound Trading -- Market Talk

26. Mai 2026, 18:03 UTC

Market Talk

AutoCanada Faces Soft Demand, Slow Normalization -- Market Talk

26. Mai 2026, 17:42 UTC

Market Talk

Grains Await Fresh Trading Catalyst -- Market Talk

26. Mai 2026, 17:33 UTC

Market Talk

Salesforce, Snowflake Could Dispel Software Bear Thesis -- Market Talk

26. Mai 2026, 17:21 UTC

Market Talk

Canada Faces a Labor Market Squeeze -- Market Talk

26. Mai 2026, 16:52 UTC

Market Talk

Bonds to Fund Infrastructure for Data Centers Could Be Risky -- Market Talk

26. Mai 2026, 16:43 UTC

Market Talk

Spotify's Latest Audio Play: Magazine Articles -- Market Talk

26. Mai 2026, 16:24 UTC

Market Talk

Dollarama's LATAM Slowdown, Australia Costs Seen as Transient -- Market Talk

26. Mai 2026, 16:21 UTC

Market Talk

Oil Extends Gains As Strikes Add Tension to U.S.-Iran Talks -- Market Talk

26. Mai 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

26. Mai 2026, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

26. Mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

26. Mai 2026, 16:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Auto & Transport Roundup: Market Talk

26. Mai 2026, 16:16 UTC

Market Talk

Alberta Separation Threat Poses Headwind for Canada Dollar -- Market Talk

26. Mai 2026, 16:01 UTC

Market Talk

Bitcoin Lower as Stress Builds for Holders -- Market Talk

26. Mai 2026, 15:21 UTC

Market Talk

Hyperliquid Pushes Up to New All-Time High -- Market Talk

Peer-Vergleich

Kursveränderung

Day One Biopharmaceuticals Inc Prognose

Kursziel

By TipRanks

-3.62% Nachteil

12-Monats-Prognose

Durchschnitt 20.75 USD -3.62%

Hoch 21.5 USD

Tief 17 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Day One Biopharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

7 ratings

Buy

Halten

Sell

Basierend auf 7 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Day One Biopharmaceuticals Inc – Dist abgegeben haben.

Stimmung

By Acuity

154 / 344 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.